Glutamic Acid

Glutamic Acid

SCHEMBL9280469

ClC1CC1.N[C@@H](CCC(=O)O)C(=O)O

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM8 O00222 2/20 0.75
GRM6 O15303 2/20 0.75
GRM7 Q14831 2/20 0.75
GRM4 Q14833 2/20 0.75
GRIN2D O15399 1/20 0.75
GRIN3B O60391 1/20 0.75
GSR P00390 1/20 0.75
CYP1A2 P05177 1/20 0.75
GRIK1 P39086 1/20 0.75
GRM5 P41594 1/20 0.75
GRIA1 P42261 1/20 0.75
GRIA2 P42262 1/20 0.75
GRIA3 P42263 1/20 0.75
SLC1A3 P43003 1/20 0.75
SLC1A2 P43004 1/20 0.75
SLC1A1 P43005 1/20 0.75
GRIA4 P48058 1/20 0.75
GRIN1 Q05586 1/20 0.75
GRIN2A Q12879 1/20 0.75
GRIK2 Q13002 1/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
D-Glutamate SCHEMBL1332297 0.87 GRM8 (1.00) GRM8GRM6GRM7GRM4GRIN2D
Glutamic Acid SCHEMBL5704264 0.87 GRM8 (1.00) GRM8GRM6GRM7GRM4GRIN2D
D-Glutamate SCHEMBL17127348 0.87 GRM8 (1.00) GRM8GRM6GRM7GRM4GRIN2D
D-Glutamate SCHEMBL2201 0.87 GRM8 (1.00) GRM8GRM6GRM7GRM4GRIN2D
D-Glutamate SCHEMBL931953 0.87 GRM8 (1.00) GRM8GRM6GRM7GRM4GRIN2D
Glutamic Acid SCHEMBL1554237 0.87 GRM8 (1.00) GRM8GRM6GRM7GRM4GRIN2D
D-Glutamate SCHEMBL410241 0.87 GRM8 (1.00) GRM8GRM6GRM7GRM4GRIN2D
D-Glutamate SCHEMBL1330484 0.87 GRM8 (1.00) GRM8GRM6GRM7GRM4GRIN2D
D-Glutamate SCHEMBL1330824 0.87 GRM8 (1.00) GRM8GRM6GRM7GRM4GRIN2D
Glutamic Acid SCHEMBL248800 0.87 GRM8 (1.00) GRM8GRM6GRM7GRM4GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114127974-B Markers for labeling biomolecules 上海宸安生物科技有限公司 2023-04-18 CN disclosed
CN-114127974-A Markers for labeling biomolecules 上海宸安生物科技有限公司 2022-03-01 CN disclosed
US-10030103-B2 Stable helical ionic polypeptides THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2018-07-24 US disclosed
EP-2646048-B1 STABLE HELICAL IONIC POLYPEPTIDES UNIV ILLINOIS (US) 2017-11-01 EP disclosed
US-20160215093-A1 STABLE HELICAL IONIC POLYPEPTIDES THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2016-07-28 US disclosed
US-9243040-B2 Stable helical ionic polypeptides THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2016-01-26 US disclosed
US-20130274173-A1 STABLE HELICAL IONIC POLYPEPTIDES THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2013-10-17 US disclosed
EP-2646048-A2 STABLE HELICAL IONIC POLYPEPTIDES The Board of Trustees of the University of Illinois (US) 2013-10-09 EP disclosed
WO-2012075147-A2 STABLE HELICAL IONIC POLYPEPTIDES BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2012-06-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10030103-B2 Stable helical ionic polypeptides GHITM, SLC7A1, PICALM GRM8 3859/4885GRM6 1569/4885GRM7 1577/4885
US-20130274173-A1 STABLE HELICAL IONIC POLYPEPTIDES GHITM, SLC7A1, PICALM GRM8 3859/4885GRM6 1569/4885GRM7 1577/4885
US-20160215093-A1 STABLE HELICAL IONIC POLYPEPTIDES GHITM, SLC7A1, PICALM GRM8 3859/4885GRM6 1569/4885GRM7 1577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.